TITLE

Drug Use and Receipt of Highly Active Antiretroviral Therapy among HIV-Infected Persons in Two U.S. Clinic Cohorts

AUTHOR(S)
McGowan, Catherine C.; Weinstein, David D.; Samenow, Charles P.; Stinnette, Samuel E.; Barkanic, Gema; Rebeiro, Peter F.; Sterling, Timothy R.; Moore, Richard D.; Hulgan, Todd
PUB. DATE
April 2011
SOURCE
PLoS ONE;2011, Vol. 6 Issue 4, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objective: Drug use and receipt of highly active antiretroviral therapy (HAART) were assessed in HIV-infected persons from the Comprehensive Care Center (CCC; Nashville, TN) and Johns Hopkins University HIV Clinic (JHU; Baltimore, MD) between 1999 and 2005. Methods: Participants with and without injection drug use (IDU) history in the CCC and JHU cohorts were evaluated. Additional analysis of persons with history of IDU, non-injection drug use (NIDU), and no drug use from CCC were performed. Activity of IDU and NIDU also was assessed for the CCC cohort. HAART use and time on HAART were analyzed according to drug use category and site of care. Results: 1745 persons were included from CCC: 268 (15%) with IDU history and 796 (46%) with NIDU history. 1977 persons were included from JHU: 731 (35%) with IDU history. Overall, the cohorts differed in IDU risk factor rates, age, race, sex, and time in follow-up. In multivariate analyses, IDU was associated with decreased HAART receipt overall (OR = 0.61, 95% CI: [0.45-0.84] and OR = 0.58, 95% CI: [0.46-0.73], respectively for CCC and JHU) and less time on HAART at JHU (0.70, [0.55- 0.88]), but not statistically associated with time on HAART at CCC (0.78, [0.56-1.09]). NIDU was independently associated with decreased HAART receipt (0.62, [0.47-0.81]) and less time on HAART (0.66, [0.52-0.85]) at CCC. These associations were not altered significantly whether patients at CCC were categorized according to historical drug use or drug use during the study period. Conclusions: Persons with IDU history from both clinic populations were less likely to receive HAART and tended to have less cumulative time on HAART. Effects of NIDU were similar to IDU at CCC. NIDU without IDU is an important contributor to HAART utilization.
ACCESSION #
61167771

 

Related Articles

  • The future of HIV care in the USA. Sherer, Renslow // Sexually Transmitted Infections;Mar2012, Vol. 88 Issue 2, p106 

    Background The number of people living with HIV in the USA increased by 50% to 1.115 million persons from 1996 to 2006 and may exceed 1.5 million by 2015. The rising caseloads are straining the HIV care system, while recession and the unknown fate of health reforms are sources of uncertainty....

  • Cancer Incidence among an HIV-infected Cohort. Johnson, C. C.; Wilcosky, T.; Kvale, P.; Rosen, M.; Stansell, J.; Glassroth, J.; Reichman, L.; Wallace, J.; Markowitz, N.; Thompson, J. E.; Hopewell, P. // American Journal of Epidemiology;1997, Vol. 146 Issue 6, p470 

    Malignancies, particularly Kaposi's sarcoma and non-Hodgkin's lymphoma (NHL), are associated with human immunodeficiency virus (HIV) infection. Cancer incidence among 1,073 asymptomatic HIV-infected individuals from the Pulmonary Complications of HIV Infection Study cohort, persons from six...

  • Outcomes of second-line combination antiretroviral therapy for HIV-infected patients: a cohort study from Rio de Janeiro, Brazil. Cardoso, Sandra Wagner; Luz, Paula Mendes; Velasque, Luciane; Torres, Thiago S.; Tavares, Isabel C.; Ribeiro, Sayonara Rocha; Moreira, Ronaldo Ismério; Veloso, Valdilea Gonçalves; Moore, Richard D.; Grinsztejn, Beatriz // BMC Infectious Diseases;2014, Vol. 14 Issue 1, p780 

    Background World-wide, the notable expansion of HIV/AIDS treatment programs in resource-limited settings has lead to an increasing number of patients in need of second-line cART. To adequately address and prepare for this scenario, critical assessments of the outcomes of second-line cART are...

  • Antiretroviral Therapy May Lower HIV Transmission Risk Within Couples. Ball, H. // International Perspectives on Sexual & Reproductive Health;Sep2010, Vol. 36 Issue 3, p160 

    The article discusses a prospective cohort analysis reported by D. Donnell et al. in a 2010 issue of "Lancet" on HIV transmission risk within couples that include a partner receiving antiretroviral therapy. Study design and statistical findings are discussed. Antiretroviral therapy...

  • Antiretroviral Regimens and CD4/CD8 Ratio Normalization in HIV-Infected Patients during the Initial Year of Treatment: A Cohort Study. De Salvador-Guillouët, F.; Sakarovitch, C.; Durant, J.; Risso, K.; Demonchy, E.; Roger, P. M.; Fontas, E. // PLoS ONE;10/20/2015, Vol. 10 Issue 10, p1 

    Background: As CD4/CD8 ratio inversion has been associated with non-AIDS morbidity and mortality, predictors of ratio normalization after cART need to be studied. Here, we aimed to investigate the association of antiretroviral regimens with CD4/CD8 ratio normalization within an observational...

  • Antiretroviral Drug Use in a Cohort of HIV-Uninfected Women in the United States: HIV Prevention Trials Network 064. Chen, Iris; Clarke, William; Ou, San-San; Marzinke, Mark A.; Breaud, Autumn; Emel, Lynda M.; Wang, Jing; Hughes, James P.; Richardson, Paul; Haley, Danielle F.; Lucas, Jonathan; Rompalo, Anne; Justman, Jessica E.; Hodder, Sally L.; Eshleman, Susan H. // PLoS ONE;10/7/2015, Vol. 10 Issue 10, p1 

    Antiretroviral (ARV) drug use was analyzed in HIV-uninfected women in an observational cohort study conducted in 10 urban and periurban communities in the United States with high rates of poverty and HIV infection. Plasma samples collected in 2009–2010 were tested for the presence of 16...

  • Predictors of Persistent Anaemia in the First Year of Antiretroviral Therapy: A Retrospective Cohort Study from Goma, the Democratic Republic of Congo. Akilimali, Pierre Zalagile; Kashala-Abotnes, Espérance; Musumari, Patou Masika; Kayembe, Patrick Kalambayi; Tylleskar, Thorkild; Mapatano, Mala Ali // PLoS ONE;10/16/2015, Vol. 10 Issue 10, p1 

    Background: Anaemia is associated with adverse outcomes including early death in the first year of antiretroviral therapy (ART). This study reports on the factors associated with persistent anaemia among HIV-infected patients initiating ART in the Democratic Republic of Congo (DR Congo)....

  • Ten-year Survival by Race/Ethnicity and Sex Among Treated, HIV-infected Adults in the United States. Lesko, Catherine R.; Cole, Stephen R.; Miller, William C.; Westreich, Daniel; Eron, Joseph J.; Adimora, Adaora A.; Moore, Richard D.; Mathews, W. Christopher; Martin, Jeffrey N.; Drozd, Daniel R.; Kitahata, Mari M.; Edwards, Jessie K.; Mugavero, Michael J. // Clinical Infectious Diseases;Jun2015, Vol. 60 Issue 11, p1700 

    Background. Ensuring equal access to antiretroviral therapy (henceforth therapy) should alleviate disparities in health outcomes among persons infected with human immunodeficiency virus (HIV). However, evidence supporting the persistence of disparities in survival following therapy initiation is...

  • Nevirapine Concentration in Hair Samples Is a Strong Predictor of Virologic Suppression in a Prospective Cohort of HIV-Infected Patients. Baxi, Sanjiv M.; Greenblatt, Ruth M.; Bacchetti, Peter; Jin, Chengshi; French, Audrey L.; Keller, Marla J.; Augenbraun, Michael H.; Gange, Stephen J.; Liu, Chenglong; Mack, Wendy J.; Gandhi, Monica; null, null // PLoS ONE;Jun2015, Vol. 10 Issue 6, p1 

    Effective antiretroviral (ARV) therapy depends on adequate drug exposure, yet methods to assess ARV exposure are limited. Concentrations of ARV in hair are the product of steady-state pharmacokinetics factors and longitudinal adherence. We investigated nevirapine (NVP) concentrations in hair as...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics